Global Endocrine Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431875
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AB Sciex Pte Ltd.
  • Abbott Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • MORE
Endocrine Testing Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global endocrine testing market was valued at US$ 7,359.4 Mn in 2016, and is expected to reach US$ 14,758.6 Mn by 2025, expanding at a CAGR of 7.9% from 2017 to 2025.

Market Insights

The endocrine systems is a setup of glands that produce and secrete hormones, vital for regulating metabolism, sexual development, body growth and other vital functions. Endocrine testing assists in determining the functioning of the endocrine glands through assessment of hormonal levels. The global endocrine testing market is driven by increasing incidence of hormonal imbalances in individuals across all age groups. Such increase in disease incidence has resulted in development of advanced diagnostic technologies thus increasing the demand for sophisticated testing methods. However, it is anticipated that significant costs involved in development of advanced testing techniques may hold back rapid commercialization of these technologies in the market, thereby restrain the market growth.

Among the various test types used in endocrine diagnostics, insulin testing and thyroid stimulating hormone test will account for the largest market share throughout the forecast period. High incidence of hyper - and hypothyroidism and increasing prevalence of diabetes are the key drivers of these segments. Additionally, being chronic in nature, these diseases demand periodic monitoring through testing methods, and at higher frequencies. This fact will ensure the dominance of these segments during the forecast period.

Based on the type of disorders, the endocrine testing market is segmented into adrenal disorders, calcium problems, glucose (islet cells) disorders, male and female gonadal problems, heart disorders, hypertensive disorders, thyroid disorders, and pituitary disorders. Among these, glucose disorders and thyroid disorders capture the highest revenue share, mainly contributed by high prevalence of these diseases. On the other hand, it is expected that diagnosis for male and female gonadal problems and heart disorders will witness the fastest growth during the forecast period on the ground of technological advancement in diagnostic techniques, enhancing their accuracy and steady rise in the incidence of the respective conditions.

On the basis of testing techniques, the global endocrine testing market is categorized into immunoassay technology, tandem mass spectrometry, sensors technology, monoclonal and polyclonal antibody technology, clinical chemistry technology and others. Tandem mass spectrometry is anticipated to witness the fastest growth during the forecast period, closely corresponded by growing accuracy of this technique and increasing application areas. The usage of endocrine testing is currently the highest in clinical laboratories and it is estimated that the same trend will continue through the forecast period.

Geographically, North America currently leads the global endocrine testing market, in terms of revenue generation. High incidence of several types of endocrine diseases, swift adoption of novel testing techniques supported by regulatory infrastructure and positive reimbursement scenario mainly contribute to the dominance of North America on the global front. Asia Pacific is observed to be the fastest progressing regional market for endocrine testing. Changes in lifestyle leading to increasing prevalence of chronic diseases and huge target population base are the prime drivers of Asia Pacific market.

Some of the market players currently enjoying prominent position in the field of endocrine testing include Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation and Teleflex Incorporated
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Sciex Pte Ltd.
  • Abbott Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Endocrine Testing Market Portraiture
2.1.1. Global Endocrine Testing Market, by Test Type, 2016
2.1.2. Global Endocrine Testing Market, by Endocrine Disorders, 2016
2.1.3. Global Endocrine Testing Market, by Testing Technology, 2016
2.1.4. Global Endocrine Testing Market, by End-user, 2016
2.1.5. Global Endocrine Testing Market, by Geography, 2016

Chapter 3. Endocrine Testing: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Test Type
4.2. Estradiol (E2) Testing
4.3. Follicle Stimulating Hormone (FSH) Testing
4.4. Human Chorionic Gonadotropin (hCG) Hormone Testing
4.5. Luteinizing Hormone (LH) Testing
4.6. Dehydroepiandrosterone Sulfate (DHEAS) Testing
4.7. Progesterone Testing
4.8. Testosterone Testing
4.9. Thyroid Stimulating Hormone (TSH) Testing
4.10. Prolactin Testing
4.11. Cortisol Testing
4.12. Insulin Testing
4.13. Others

Chapter 5. Global Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition, by Endocrine Disorders
5.2. Adrenal Disorders
5.3. Calcium Problems
5.4. Glucose (islet cells) Disorders
5.5. Male and Female Gonadal Problems
5.6. Heart Disorders
5.7. Hypertensive Disorders
5.8. Thyroid Disorders
5.9. Pituitary Disorders

Chapter 6. Global Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition, by Testing Technology
6.2. Immunoassay Technology
6.3. Tandem Mass Spectrometry
6.4. Sensors Technology
6.5. Monoclonal and Polyclonal Antibody Technology
6.6. Clinical Chemistry Technology
6.7. Others

Chapter 7. Global Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
7.1. Overview
7.1.1. Attractive Investment Proposition, by Testing Technology
7.2. Hospitals
7.3. Clinical Laboratories
7.4. Research and Academia
7.5. Others

Chapter 8. Global Endocrine Testing Market, by Geography, 2015 - 2025
8.1. Overview
8.2. North America Endocrine Testing Market Analysis, 2015 - 2025
8.2.1. North America Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
8.2.2. North America Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
8.2.3. North America Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
8.2.4. North America Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
8.2.5. North America Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe Endocrine Testing Market Analysis, 2015 - 2025
8.3.1. Europe Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
8.3.2. Europe Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
8.3.3. Europe Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
8.3.4. Europe Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
8.3.5. Europe Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. Asia Pacific Endocrine Testing Market Analysis, 2015 - 2025
8.4.1. Asia Pacific Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
8.4.2. Asia Pacific Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
8.4.3. Asia Pacific Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
8.4.4. Asia Pacific Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
8.4.5. Asia Pacific Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
8.4.5.1. China
8.4.5.2. Japan
8.4.5.3. Rest of Asia Pacific
8.5. Latin America Endocrine Testing Market Analysis, 2015 - 2025
8.5.1. Latin America Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
8.5.2. Latin America Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
8.5.3. Latin America Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
8.5.4. Latin America Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
8.5.5. Latin America Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East & Africa Endocrine Testing Market Analysis, 2015 - 2025
8.6.1. MEA Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
8.6.2. MEA Endocrine Testing Market, by Endocrine Disorders, 2015 - 2025 (US$ Mn)
8.6.3. MEA Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
8.6.4. MEA Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
8.6.5. MEA Endocrine Testing Market, by Region, 2015 - 2025 (US$ Mn)
8.6.5.1. GCC
8.6.5.2. Rest of Middle East and Africa

Chapter 9. Company Profiles
9.1. Abbott Laboratories, Inc.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Testing Technology Portfolio
9.1.4. Key Developments
9.2. AB Sciex Pte Ltd.
9.3. Agilent Technologies, Inc.
9.4. Biomedical Technologies (Alfa Aesar)
9.5. bioMérieux SA
9.6. Bio-Rad Laboratories, Inc.
9.7. DiaSorin
9.8. F. Hoffmann-La Roche Ltd.
9.9. Laboratory Corporation of America Holdings
9.10. Ortho-clinical Diagnostics
9.11. Quest Technology Pte Ltd.
9.12. Sysmex Corporation
9.13. Teleflex Incorporated

List of Figures
Fig. 1 Endocrine Testing: Market Segmentation
Fig. 2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
Fig. 3 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
Fig. 4 Global Endocrine Testing Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography
Fig. 6 Market Competition Landscape, by Key Players, 2016
Fig. 7 Attractive Investment Proposition, by Test Type
Fig. 8 Global Estradiol (E2) Testing Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Follicle Stimulating Hormone (FSH) Testing Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Human Chorionic Gonadotropin (hCG) Hormone Testing Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Luteinizing Hormone (LH) Testing Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Testing Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Progesterone Testing Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Testosterone Testing Market, 2015 - 2025 (US$ Mn)
Fig. 15 Global Thyroid Stimulating Hormone (TSH) Testing Market, 2015 - 2025 (US$ Mn)
Fig. 16 Global Prolactin Testing Market, 2015 - 2025 (US$ Mn)
Fig. 17 Global Cortisol Testing Market, 2015 - 2025 (US$ Mn)
Fig. 18 Global Insulin Testing Market, 2015 - 2025 (US$ Mn)
Fig. 19 Global Other Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 20 Attractive Investment Proposition, by Endocrine Disorders
Fig. 21 Global Endocrine Testing Market for Adrenal Disorders, 2015 - 2025 (US$ Mn)
Fig. 22 Global Endocrine Testing Market for Calcium Problems, 2015 - 2025 (US$ Mn)
Fig. 23 Global Endocrine Testing Market for Glucose (islet cells) Disorders, 2015 - 2025 (US$ Mn)
Fig. 24 Global Endocrine Testing Market for Male and Female Gonadal Problems, 2015 - 2025 (US$ Mn)
Fig. 25 Global Endocrine Testing Market for Heart Disorders, 2015 - 2025 (US$ Mn)
Fig. 26 Global Endocrine Testing Market for Hypertensive Disorders, 2015 - 2025 (US$ Mn)
Fig. 27 Global Endocrine Testing Market for Thyroid Disorders, 2015 - 2025 (US$ Mn)
Fig. 28 Global Endocrine Testing Market for Pituitary Disorders, 2015 - 2025 (US$ Mn)
Fig. 29 Attractive Investment Proposition, by Testing Technology
Fig. 30 Global Endocrine Testing Market for Immunoassay Technology, 2015 - 2025 (US$ Mn)
Fig. 31 Global Endocrine Testing Market for Tandem Mass Spectrometry, 2015 - 2025 (US$ Mn)
Fig. 32 Global Endocrine Testing Market for Sensors Technology, 2015 - 2025 (US$ Mn)
Fig. 33 Global Endocrine Testing Market for Monoclonal and Polyclonal Antibody Technology, 2015 - 2025 (US$ Mn)
Fig. 34 Global Endocrine Testing Market for Clinical Chemistry Technology, 2015 - 2025 (US$ Mn)
Fig. 35 Global Endocrine Testing Market for Other Technologies, 2015 - 2025 (US$ Mn)
Fig. 36 Attractive Investment Proposition, by End-user
Fig. 37 Global Endocrine Testing Market in Hospitals, 2015 - 2025 (US$ Mn)
Fig. 38 Global Endocrine Testing Market in Clinical Laboratories, 2015 - 2025 (US$ Mn)
Fig. 39 Global Endocrine Testing Market in Research and Academia, 2015 - 2025 (US$ Mn)
Fig. 40 Global Endocrine Testing Market in Other End-uses, 2015 - 2025 (US$ Mn)
Fig. 41 U.S. Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 42 Canada Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 43 U.K. Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 44 Germany Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 45 France Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 46 Italy Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 47 Spain Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 48 Rest of Europe Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 49 China Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 50 Japan Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 51 Rest of Asia Pacific Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 52 Brazil Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 53 Mexico Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 54 Rest of Latin America Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 55 GCC Endocrine Testing Market, 2015 - 2025 (US$ Mn)
Fig. 56 Rest of Middle East and Africa Endocrine Testing Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 2 Global Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 3 Global Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 4 Global Endocrine Testing Market, by End-user, 2015 - 2025 (US$ Mn)
Table 5 North America Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 6 North America Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 7 North America Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 8 North America Endocrine Testing Market, by End User, 2015 - 2025 (US$ Mn)
Table 9 North America Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Europe Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 11 Europe Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 12 Europe Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 13 Europe Endocrine Testing Market, by End User, 2015 - 2025 (US$ Mn)
Table 14 Europe Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
Table 15 Asia Pacific Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 16 Asia Pacific Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 17 Asia Pacific Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 18 Asia Pacific Endocrine Testing Market, by End User, 2015 - 2025 (US$ Mn)
Table 19 Asia Pacific Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
Table 20 Latin America Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 21 Latin America Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 22 Latin America Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 23 Latin America Endocrine Testing Market, by End User, 2015 - 2025 (US$ Mn)
Table 24 Latin America Endocrine Testing Market, by Country, 2015 - 2025 (US$ Mn)
Table 25 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 - 2025 (US$ Mn)
Table 26 Middle East and Africa Endocrine Testing Market, by Endocrine Disorder, 2015 - 2025 (US$ Mn)
Table 27 Middle East and Africa Endocrine Testing Market, by Testing Technology, 2015 - 2025 (US$ Mn)
Table 28 Middle East and Africa Endocrine Testing Market, by End User, 2015 - 2025 (US$ Mn)
Table 29 Middle East and Africa Endocrine Testing Market, by Region, 2015 - 2025 (US$ Mn)
Table 30 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 31 AB Sciex Pte Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 32 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 33 Biomedical Technologies (Alfa Aesar): Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 34 bioMérieux SA: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 35 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 36 DiaSorin: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 37 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 38 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 39 Ortho-clinical Diagnostics: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 40 Quest Technology Pte Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 41 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Table 42 Teleflex Incorporated: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • AB Sciex Pte Ltd.
  • Agilent Technologies, Inc.
  • Biomedical Technologies (Alfa Aesar)
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll